BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36832194)

  • 1. Role of Diffusion-Weighted Magnetic Resonance Imaging for Characterization of Mediastinal Lymphadenopathy.
    Ramamoorthy E; Garg M; Singh P; Aggarwal AN; Gupta N
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mediastinal lymphadenopathy by diffusion weighted MRI; correlation with histopathological results.
    Abou Youssef HA; Elzorkany MA; Hussein SA; Taymour TA; Abdel Gawad MH
    Adv Respir Med; 2019; 87(3):175-183. PubMed ID: 31282559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
    Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
    Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of Malignant versus Benign Mediastinal Lymph Nodes Using Diffusion MRI with an IVIM Model.
    Qi LP; Yan WP; Chen KN; Zhong Z; Li XT; Cai K; Sun YS; Zhou XJ
    Eur Radiol; 2018 Mar; 28(3):1301-1309. PubMed ID: 28929210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary exploration of the intravoxel incoherent motion applied in the preoperative evaluation of mediastinal lymph node metastasis of lung cancer.
    Ye X; Chen S; Tian Y; You B; Zhang W; Zhao Y; Jiang T; Hu B; Li H
    J Thorac Dis; 2017 Apr; 9(4):1073-1080. PubMed ID: 28523162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion Tensor Imaging in Characterization of Mediastinal Lymphadenopathy.
    Abdel Razek AAK; Baky KA; Helmy E
    Acad Radiol; 2022 Feb; 29 Suppl 2():S165-S172. PubMed ID: 34736860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging of mediastinal lymphadenopathy in children.
    Abdel Razek AA; Gaballa G; Elashry R; Elkhamary S
    Jpn J Radiol; 2015 Aug; 33(8):449-54. PubMed ID: 26067466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent Diffusion Coefficient Measurement in Mediastinal Lymphadenopathies: Differentiation between Benign and Malignant Lesions.
    Ustabasioglu FE; Samanci C; Alis D; Samanci NS; Kula O; Olgun DC
    J Clin Imaging Sci; 2017; 7():12. PubMed ID: 28400998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of diffusion-weighted MR imaging in cervical lymphadenopathy.
    Abdel Razek AA; Soliman NY; Elkhamary S; Alsharaway MK; Tawfik A
    Eur Radiol; 2006 Jul; 16(7):1468-77. PubMed ID: 16557366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of apparent diffusion coefficient for differentiating peripancreatic tuberculous lymphadenopathy from metastatic lymphadenopathy.
    Huh J; Byun JH; Kim JH; Lee SS; Kim HJ; Kim JK; Lee MG
    Abdom Radiol (NY); 2020 Oct; 45(10):3163-3171. PubMed ID: 32240328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy.
    Zhang Y; Chen J; Shen J; Zhong J; Ye R; Liang B
    Clin Radiol; 2013 Mar; 68(3):224-31. PubMed ID: 22316593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient in Gastric Cancer Staging.
    Soydan L; Demir AA; Torun M; Cikrikcioglu MA
    Curr Med Imaging; 2020; 16(10):1278-1289. PubMed ID: 32108000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
    Xu L; Tian J; Liu Y; Li C
    J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values.
    Wang T; Li W; Wu X; Yin B; Chu C; Ding M; Cui Y
    PLoS One; 2016; 11(2):e0149318. PubMed ID: 26894926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of lymphoma versus sarcoidosis in the setting of mediastinal-hilar lymphadenopathy: assessment with diffusion-weighted MR imaging.
    Gümüştaş S; Inan N; Akansel G; Başyïğït I; Cïftçi E
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):52-9. PubMed ID: 24003535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.
    Sumi M; Sakihama N; Sumi T; Morikawa M; Uetani M; Kabasawa H; Shigeno K; Hayashi K; Takahashi H; Nakamura T
    AJNR Am J Neuroradiol; 2003 Sep; 24(8):1627-34. PubMed ID: 13679283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma.
    Vijayalakshmi K; Raghuram PH; Saravanan K; Krithika CL; Kannan A
    J Cancer Res Ther; 2020; 16(3):587-593. PubMed ID: 32719272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.